Physician profile
Maria E Wilson
NPI 1720344906
$1,530.21
in general payments reported to CMS, 2019-2025
13 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.91 · 2020: $17.54 · 2021: $453 · 2022: $302 · 2024: $536 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $763.43 | 2019-2022 | |
| Abbott Laboratories | $144.36 | 2024 | Freestyle Libre 3 |
| Madrigal Pharmaceuticals | $121.18 | 2024 | Rezdiffra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.33 | 2024 | Jardiance |
| Biotronik Nro, INC. | $84.85 | 2024 | Prospera |
| Novo Nordisk INC | $76.84 | 2024-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $57.90 | 2019 | |
| Exact Sciences Corporation | $50.48 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $45.95 | 2019-2022 | |
| Gilead Sciences, INC. | $29.99 | 2025 | |
| Lilly USA, LLC | $19.94 | 2024 | Mounjaro |
| Pfizer INC. | $18.96 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.